Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 8:01 p.m.

    📋 Form 144 Filing: Lippman Evan

    Company: TEVA PHARMACEUTICAL INDUSTRIES LTD

    Filing Date: 2026-08-17

    Relationship: Officer; EVP BUSINESS DEVELOPMENT

    Planned Sale Details:

    • Security: ORDINARY SHARES
    • Shares to be Sold: 18,600
    • Price per Share: $36.57
    • Total Value: $680,291.39
    • Planned Sale Date: 2026-08-17
    • Broker: CITIGROUP GLOBAL MARKETS
    • Exchange: NYSE

    Additional Information:

    • SEC File Number: 001-16174
    • Issuer Contact Phone: 972 (3) 914-8213
    • Issuer Address: TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, L3, 6944020
    • Broker Address: 390 GREENWICH ST, NEW YORK, NY, 10013
    • Shares Outstanding: 1165296084.0
    • Number of Securities to be Sold: 1
    • Remarks: The transaction is part of a 10B5-1 plan dated 5-16-2026.
    • Signature: CONFORMED SIGNATURE ON FILE

Search

News categories